Skip to main content
. 2017 Sep 8;12(9):e0184178. doi: 10.1371/journal.pone.0184178

Table 1. Dermographic features.

Age (years) 47.16 ± 13.14a
Sex, n (%) Man: 101 (75.4)
Woman: 33 (24.6)
With psoriatic arthritis, n (%) 42 (32.1)
Mean follow-up months 20.5 ± 10.52a
Previous biological treatment, n (%) Etanercept: 24 (17.9)
Adalimumab: 23 (17.2)
Combined treatment, n (%) Methotrexate: 12 (9)
Etanercept: 4 (3)
Adalimumab: 1(0.7)

aStandard deviation